Early detection improves cancer survival rates. Autoantibodies can appear very early in disease, often long before onset of symptoms.
Read the white paper to learn:
- Mechanisms that induce autoantibodies in cancer
- Discovering autoantibody panels predictive of patient outcomes and responses to therapy
- Key approaches to screening for autoantibodies with high specificity and sensitivity